Date: Wednesday, July 11th, 2018
Source: Investor’s Business Daily (http://www.investors.com)
An agreement by Dow Jones component Pfizer to defer drug price increases in an effort to play nice with President Donald Trump led analysts Wednesday to question what the fallout of the drug giant’s action would be for the industry.
The post Pfizer Opts To Defer Price Hikes Amid Trump Scrutiny — So, Who’s Next? appeared first on Investor’s Business Daily.
Full article address: https://www.investors.com/news/technology/pfizer-restructuring-price-increases/